Literature DB >> 33996237

Deep-learning-aided forward optical coherence tomography endoscope for percutaneous nephrostomy guidance.

Chen Wang1,2, Paul Calle1,2, Nu Bao Tran Ton1, Zuyuan Zhang3, Feng Yan1, Anthony M Donaldson1, Nathan A Bradley4, Zhongxin Yu5, Kar-Ming Fung6,7, Chongle Pan3,8, Qinggong Tang1,9.   

Abstract

Percutaneous renal access is the critical initial step in many medical settings. In order to obtain the best surgical outcome with minimum patient morbidity, an improved method for access to the renal calyx is needed. In our study, we built a forward-view optical coherence tomography (OCT) endoscopic system for percutaneous nephrostomy (PCN) guidance. Porcine kidneys were imaged in our experiment to demonstrate the feasibility of the imaging system. Three tissue types of porcine kidneys (renal cortex, medulla, and calyx) can be clearly distinguished due to the morphological and tissue differences from the OCT endoscopic images. To further improve the guidance efficacy and reduce the learning burden of the clinical doctors, a deep-learning-based computer aided diagnosis platform was developed to automatically classify the OCT images by the renal tissue types. Convolutional neural networks (CNN) were developed with labeled OCT images based on the ResNet34, MobileNetv2 and ResNet50 architectures. Nested cross-validation and testing was used to benchmark the classification performance with uncertainty quantification over 10 kidneys, which demonstrated robust performance over substantial biological variability among kidneys. ResNet50-based CNN models achieved an average classification accuracy of 82.6%±3.0%. The classification precisions were 79%±4% for cortex, 85%±6% for medulla, and 91%±5% for calyx and the classification recalls were 68%±11% for cortex, 91%±4% for medulla, and 89%±3% for calyx. Interpretation of the CNN predictions showed the discriminative characteristics in the OCT images of the three renal tissue types. The results validated the technical feasibility of using this novel imaging platform to automatically recognize the images of renal tissue structures ahead of the PCN needle in PCN surgery.
© 2021 Optical Society of America under the terms of the OSA Open Access Publishing Agreement.

Entities:  

Year:  2021        PMID: 33996237      PMCID: PMC8086467          DOI: 10.1364/BOE.421299

Source DB:  PubMed          Journal:  Biomed Opt Express        ISSN: 2156-7085            Impact factor:   3.732


  5 in total

1.  Visually guided chick ocular length and structural thickness variations assessed by swept-source optical coherence tomography.

Authors:  Feng Yan; Chen Wang; Jayla A Wilson; Michael O'Connell; Sam Ton; Noah Davidson; Mourren Sibichan; Kari Chambers; Ahmed Ahmed; Jody Summers; Qinggong Tang
Journal:  Biomed Opt Express       Date:  2021-10-13       Impact factor: 3.732

2.  Feasibility of the soft attention-based models for automatic segmentation of OCT kidney images.

Authors:  Mousa Moradi; Xian Du; Tianxiao Huan; Yu Chen
Journal:  Biomed Opt Express       Date:  2022-04-11       Impact factor: 3.562

3.  Epidural anesthesia needle guidance by forward-view endoscopic optical coherence tomography and deep learning.

Authors:  Chen Wang; Paul Calle; Justin C Reynolds; Sam Ton; Feng Yan; Anthony M Donaldson; Avery D Ladymon; Pamela R Roberts; Alberto J de Armendi; Kar-Ming Fung; Shashank S Shettar; Chongle Pan; Qinggong Tang
Journal:  Sci Rep       Date:  2022-05-31       Impact factor: 4.996

4.  Computer-aided Veress needle guidance using endoscopic optical coherence tomography and convolutional neural networks.

Authors:  Chen Wang; Justin C Reynolds; Paul Calle; Avery D Ladymon; Feng Yan; Yuyang Yan; Sam Ton; Kar-Ming Fung; Sanjay G Patel; Zhongxin Yu; Chongle Pan; Qinggong Tang
Journal:  J Biophotonics       Date:  2022-02-11       Impact factor: 3.390

5.  Inflation of test accuracy due to data leakage in deep learning-based classification of OCT images.

Authors:  Iulian Emil Tampu; Anders Eklund; Neda Haj-Hosseini
Journal:  Sci Data       Date:  2022-09-22       Impact factor: 8.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.